Novocure (NASDAQ: NVCR) reported Q2 EPS of ($0.23), $0.08 worse than the analyst estimate of ($0.15). Revenue for the quarter came in at $140.9 million versus the consensus estimate of $135.33 million.

For earnings history and earnings-related data on Novocure (NVCR) click here.